SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-067423
Filing Date
2015-11-23
Accepted
2015-11-23 11:11:09
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v424419_10q.htm 10-Q 551708
2 EXHIBIT 31.1 v424419_ex31-1.htm EX-31.1 8948
3 EXHIBIT 31.2 v424419_ex31-2.htm EX-31.2 8982
4 EXHIBIT 32.1 v424419_ex32-1.htm EX-32.1 5306
  Complete submission text file 0001144204-15-067423.txt   4414166

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aktx-20150930.xml EX-101.INS 914947
6 XBRL TAXONOMY EXTENSION SCHEMA aktx-20150930.xsd EX-101.SCH 45636
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20150930_cal.xml EX-101.CAL 39216
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20150930_def.xml EX-101.DEF 283708
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20150930_lab.xml EX-101.LAB 318314
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20150930_pre.xml EX-101.PRE 331566
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 151248739
SIC: 2834 Pharmaceutical Preparations